Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization
- PMID: 9353022
- PMCID: PMC175643
- DOI: 10.1128/iai.65.11.4476-4482.1997
Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization
Abstract
V antigen of Yersinia pestis is a multifunctional protein that has been implicated as a protective antigen, a virulence factor, and a regulatory protein. A series of V-antigen truncates expressed as glutathione S-transferase (GST) fusion proteins (GST-V truncates) have been cloned and purified to support immunogenicity and functionality studies of V antigen. Immunization studies with GST-V truncates have identified two regions of V antigen that confer protection against Y. pestis 9B (a fully virulent human pneumonic plague isolate) in a mouse model for plague. A minor protective region is located from amino acids 2 to 135 (region I), and a major protective region is found between amino acids 135 and 275 (region II). In addition, analysis of IgG titers following immunization suggested that the major antigenic region of V antigen is located between amino acids 135 and 245. A panel of monoclonal antibodies raised against recombinant V antigen was characterized by Western blotting against GST-V truncates, and epitopes of most of the monoclonal antibodies were mapped to region I or II. Monoclonal antibody 7.3, which recognizes an epitope in region II, passively protected mice against challenge with 12 median lethal doses of Y. pestis GB, indicating that region II encodes a protective epitope. This is the first report of a V-antigen-specific monoclonal antibody that will protect mice against a fully virulent strain of Y. pestis. The combined approach of passive and active immunization has therefore confirmed the importance of the central region of the protein for protection and also identified a previously unknown protective region at the N terminus of V antigen.
Similar articles
-
Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.PLoS Negl Trop Dis. 2019 Aug 20;13(8):e0007644. doi: 10.1371/journal.pntd.0007644. eCollection 2019 Aug. PLoS Negl Trop Dis. 2019. PMID: 31430284 Free PMC article.
-
Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague.Infect Immun. 1995 Aug;63(8):2854-8. doi: 10.1128/iai.63.8.2854-2858.1995. Infect Immun. 1995. PMID: 7622205 Free PMC article.
-
Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.Microb Pathog. 1997 Sep;23(3):167-79. doi: 10.1006/mpat.1997.0141. Microb Pathog. 1997. PMID: 9281474
-
Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.Hum Gene Ther. 2010 Jul;21(7):891-901. doi: 10.1089/hum.2009.148. Hum Gene Ther. 2010. PMID: 20180652 Free PMC article.
-
Potential human immunotherapeutics for plague.Immunother Adv. 2021 Oct 5;1(1):ltab020. doi: 10.1093/immadv/ltab020. eCollection 2021 Jan. Immunother Adv. 2021. PMID: 35919741 Free PMC article. Review.
Cited by
-
Evaluation of human antibodies from vaccinated volunteers for protection against Yersinia pestis infection.Microbiol Spectr. 2024 Oct 3;12(10):e0105424. doi: 10.1128/spectrum.01054-24. Epub 2024 Aug 27. Microbiol Spectr. 2024. PMID: 39189763 Free PMC article.
-
Administration of antibody to the lung protects mice against pneumonic plague.Infect Immun. 2006 May;74(5):3068-70. doi: 10.1128/IAI.74.5.3068-3070.2006. Infect Immun. 2006. PMID: 16622253 Free PMC article.
-
Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.Infect Immun. 2008 Aug;76(8):3640-50. doi: 10.1128/IAI.00050-08. Epub 2008 May 27. Infect Immun. 2008. PMID: 18505806 Free PMC article.
-
Virulence role of V antigen of Yersinia pestis at the bacterial surface.Infect Immun. 1999 Oct;67(10):5395-408. doi: 10.1128/IAI.67.10.5395-5408.1999. Infect Immun. 1999. PMID: 10496922 Free PMC article.
-
TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.Vaccine. 2010 Dec 16;29(2):357-62. doi: 10.1016/j.vaccine.2010.08.099. Epub 2010 Sep 15. Vaccine. 2010. PMID: 20840834 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials